COVID-19 vaccines for patients with haematological conditions

Lancet Haematol. 2021 May;8(5):e312-e314. doi: 10.1016/S2352-3026(21)00073-9. Epub 2021 Mar 31.

Authors

Clare Sun¹, Christopher Pleyer², Adrian Wiestner²

Affiliations

¹ Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: clare.sun@nih.gov.
² Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

No abstract available

Publication types

Research Support, N.I.H., Intramural

MeSH terms

COVID-19 / complications*
COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 Vaccines / adverse effects
COVID-19 Vaccines / immunology
COVID-19 Vaccines / therapeutic use*
Hematologic Diseases / complications*
Hematologic Diseases / immunology
Hematologic Neoplasms / complications
Hematologic Neoplasms / immunology
Humans
Immunogenicity, Vaccine
SARS-CoV-2 / immunology

Substances

COVID-19 Vaccines